Vivo Bio Tech Limited (BOM:511509)

Market Cap	629.99M -19.0%
Revenue (ttm)	471.83M +2.3%
Net Income	45.17M -35.1%
EPS	2.34 -43.8%
Shares Out	22.19M
PE Ratio	12.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,453
Average Volume	19,791
Open	29.39
Previous Close	28.90
Day's Range	28.51 - 29.39
52-Week Range	25.20 - 44.90
Beta	0.00
RSI	44.88
Earnings Date	Feb 13, 2026

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In fiscal year 2025, Vivo Bio Tech's revenue was 466.73 million, an increase of 2.69% compared to the previous year's 454.51 million. Earnings were 72.83 million, an increase of 188.27%.